ULTRASE MT 20 (Ultrase MT 20 65,000 units amylase; 20,000 units lipase; 65,000 units protease)
Generic Name: pancrelipase
Pill imprint ULTRASE MT 20 has been identified as Ultrase MT 20 65,000 units amylase; 20,000 units lipase; 65,000 units protease.
Ultrase MT 20 is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Ultrase MT 20 65,000 units amylase; 20,000 units lipase; 65,000 units protease is not subject to the Controlled Substances Act.
See also related documents.
Images for ULTRASE MT 20 (Ultrase MT 20 65,000 units amylase; 20,000 units lipase; 65,000 units protease)
- Generic Name:
- pancrelipase
- Imprint:
-
ULTRASE
MT 20 - Strength:
- 65,000 units amylase; 20,000 units lipase; 65,000 units protease
- Color:
- Gray / Yellow
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Digestive enzymes
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Axcan Scandipharm Inc.
- National Drug Code (NDC):
- 58914-0004
More resources
Ultrase MT 20 is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
